An in vitro comparative study of the antioxidant activity and SIRT1 modulation of natural compounds

Biomedicine and Pharmacotherapy

Volumn 101, Issue , 2018, Pages 805-819

  Fusi, Jonathan ^a   Bianchi, Sara ^a   Daniele, Simona ^a   Pellegrini, Silvia ^a   Martini, Claudia ^a   Galetta, Fabio ^a   Giovannini, Luca ^a   Franzoni, Ferdinando ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

AMPK; Antioxidants; Berberine; Oxidative stress; Polyphenols; SIRT1

Indexed keywords

BERBERINE; CATECHIN; CURCUMIN; FERULIC ACID; GLUTATHIONE; GLUTATHIONE DISULFIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; NATURAL PRODUCT; QUERCETIN; SIRTUIN 1; TROLOX C; TYROSOL; URIC ACID; AMP-ACTIVATED PROTEIN KINASE KINASE; ANTIOXIDANT; BIOLOGICAL FACTOR; PROTEIN KINASE; SIRT1 PROTEIN, HUMAN;

ANTIOXIDANT ACTIVITY; ANTIOXIDANT ASSAY; ARTICLE; CELL VIABILITY; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; FEMALE; FENTON REACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID PEROXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; BIOSYNTHESIS; CELL SURVIVAL; DRUG EFFECT; HELA CELL LINE; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY;

ANTIOXIDANTS; BERBERINE; BIOLOGICAL FACTORS; CELL SURVIVAL; CURCUMIN; HELA CELLS; HUMANS; OXIDATIVE STRESS; PROTEIN KINASES; QUERCETIN; SIRTUIN 1;

EID: 85043372557     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2018.03.006     Document Type: Article

References (123)

1. Saeidnia, S., Abdollahi, M., Toxicological and pharmacological concerns on oxidative stress and related diseases. Toxicol. Appl. Pharmacol. 273 (2013), 442–455, 10.1016/j.taap.2013.09.031.
2. Pham-Huy, L.A., He, H., Pham-Huy, C., Free radicals, antioxidants in disease and health. Int. J. Biomed. Sci. 4 (2008), 89–96.
3. Duracková, Z., Some current insights into oxidative stress. Physiol. Res. 59 (2010), 459–469 Review.
4. Thannickal, V.J., Fanburg, B.L., Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell. Mol. Physiol. 279 (2000), L1005–L1028.
5. Hussain, S.P., Hofseth, L.J., Harris, C.C., Radical causes of cancer. Nat. Rev. Cancer 3 (2003), 276–285 Review.
6. Poljsak, B., Strategies for reducing or preventing the generation of oxidative stress. Oxid. Med. Cell. Longev., 2011, 2011, 194586, 10.1155/2011/194586 Review.
7. Karadag, A., Ozcelik, B., Saner, S., Review of methods to determine antioxidant capacities. Food Anal. Methods 2 (2009), 41–60.
8. Finley, J.W., Kong, A.N., Hintze, K.J., Jeffery, E.H., Ji, L.L., Lei, X.G., Antioxidants in foods: state of the science important to the food industry. J. Agric. Food Chem. 59 (2011), 6837–6846, 10.1021/jf2013875 Review.
9. Kumar, S., Pandey, A.K., Free radicals: health implications and their mitigation by herbals. Br. J. Med. Med. Res. 7 (2015), 438–457.
10. Kim, M.J., Hyun, J.N., Kim, J.A., et al. Relationship between phenolic compounds, anthocyanins content and antioxidant activity in colored barley germplasm. J. Agric. Food Chem. 55 (2007), 4802–4809.
11. Omwamba, M., Li, F., Sun, G., et al. Antioxidant effect of roasted barley (Hordeum vulgare L.) grain extract towards oxidative stress in vitro and in vivo. Food Nutr. Sci. 4 (2013), 139–146, 10.4236/fns.2013.48A017.
12. Bruckbauer, A., Zemel, M.B., Synergistic effects of polyphenols and methylxanthines with leucine on AMPK/Sirtuin-mediated metabolism in muscle cells and adipocytes. PLoS One, 2014, 10.1371/journal.pone.0089166.
13. Wang, S., Moustaid-Moussa, N., Chen, L., et al. Novel insights of dietary polyphenols and obesity. J. Nutr. Biochem. 25 (2014), 1–18, 10.1016/j.jnutbio.2013.09.001.
14. Kumar, S., Pandey, A.K., Chemistry and biological activities of flavonoids: an overview. Sci. World J., 2013, 2013, 162750, 10.1155/2013/162750.
15. Neveu, V., Perez-Jiménez, J., Vos, F., et al. Phenol-explorer: an online comprehensive database on polyphenol contents in foods. Database (Oxf.), 2010, 2010, 10.1093/database/bap024 bap024.
16. Manach, C., Williamson, G., Morand, C., et al. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 81 (2005), 230S–242S Review.
17. Malongane, F., McGaw, L.J., Mudau, F.N., The synergistic potential of various teas, herbs and therapeutic drugs in health improvement: a review. J. Sci. Food Agric., 2017, 10.1002/jsfa.8472.
18. Shirwaikar, A., Shirwaikar, A., Rajendran, K., Punitha, I.S.R., In vitro antioxidant studies on the benzyl tetra isoquinoline alkaloid berberine. Biol. Pharm. Bull. 29 (2006), 1906–1910.
19. Kong, W., Wei, J., Abidi, P., et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat. Med. 10 (2004), 1344–1351, 10.1038/nm1135.
20. Jin, Y., Khadka, D.B., Cho, W.J., Pharmacological effects of berberine and its derivatives: a patent update. Expert Opin. Ther. Pat. 26 (2016), 229–243, 10.1517/13543776.2016.1118060.
21. Wen, S.Q., Jeyakkumar, P., Avula, S.R., et al. Discovery of novel berberine imidazoles as safe antimicrobial agents by down regulating ROS generation. Bioorg. Med. Chem. Lett. 26 (2016), 2768–2773, 10.1016/j.bmcl.2016.04.070.
22. The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett. 203 (2004), 127–137.
23. Sadeghnia, H.R., Kolangikhah, M., Asadpour, E., et al. Berberine protects against glutamate-induced oxidative stress and apoptosis in PC12 and N2a cells. Iran. J. Basic Med. Sci. 20 (2017), 594–603, 10.22038/IJBMS.2017.8847.
24. Zhang, L.C., Wang, Y., Tong, L.C., et al. Berberine alleviates dextran sodium sulfate-induced colitis by improving intestinal barrier function and reducing inflammation and oxidative stress. Exp. Ther. Med. 13 (2017), 3374–3382, 10.3892/etm.2017.4402.
25. Chen, D.L., Yang, K.Y., Berberine alleviates oxidative stress in islets of diabetic mice by inhibiting miR-106b expression and up-regulating SIRT1. J. Cell. Biochem., 2017, 10.1002/jcb.26089.
26. Li, W., Liu, Y., Wang, B., et al. Protective effect of berberine against oxidative stress-induced apoptosis in rat bone marrow-derived mesenchymal stem cells. Exp. Ther. Med. 12 (2016), 4041–4048, 10.3892/etm.2016.3866.
27. Narala, S.R., Allsopp, R.C., Wells, T.B., et al. SIRT1 acts as a nutrient-sensitive growth suppressor and its loss is associated with increased AMPK and telomerase activity. Mol. Biol. Cell. 19 (2008), 1210–1219, 10.1091/mbc.E07-09-0965.
28. Hardie, D.G., AMPK: positive and negative regulation, and its role in whole-body energy homeostasis. Curr. Opin. Cell Biol. 33 (2015), 1–7, 10.1016/j.ceb.2014.09.004.
29. Shirwany, N.A., Zou, M.H., AMPK: a cellular metabolic and redox sensor. A minireview. Front. Biosci. 19 (2014), 447–474 Review.
30. Sun, Y., Li, J., Xiao, N., et al. Pharmacological activation of AMPK ameliorates perivascular adipose/endothelial dysfunction in a manner interdependent on AMPK and SIRT1. Pharmacol. Res. 89 (2014), 19–28, 10.1016/j.phrs.2014.07.006.
31. Naiman, S., Cohen, H.Y., The contentious history of sirtuin debates. Rambam Maimonides Med. J., 3, 2012, 10.5041/RMMJ.10093.
32. Houtkooper, R.H., Pirinen, E., Auwerx, J., Sirtuins as regulators of metabolism and healthspan. Nat. Rev. Mol. Cell Biol. 13 (2012), 225–238, 10.1038/nrm3293.
33. Chang, H.C., Guarente, L., SIRT1 and other sirtuins in metabolism. Trends Endocrinol. Metab. 25 (2014), 138–145, 10.1016/j.tem.2013.12.001.
34. Davenport, A.M., Huber, F.M., Hoelz, A., Structural and functional analysis of human SIRT1. J. Mol. Biol. 426 (2014), 526–541, 10.1016/j.jmb.2013.10.009.
35. Yakamoto, H., Schoonjans, L., Auwerx, J., Sirtuin functions in health and disease. Mol. Endocrinol. 21 (2007), 1745–1755.
36. Kwon, H.S., Ott, M., The ups and downs of SIRT1. Trends Biochem. Sci. 33 (2008), 517–525, 10.1016/j.tibs.2008.08.001.
37. Cantó, C., Gerhart-Hines, Z., Feige, J.N., et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458 (2009), 1050–1060, 10.1038/nature07813.
38. Lan, F., Cacicedo, J.M., Ruderman, N., et al. SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. J. Biol. Chem. 283 (2008), 27628–27635, 10.1074/jbc.M805711200.
39. Bianchi, S., Fusi, J., Franzoni, F., et al. Effects of recombinant human erythropoietin high mimicking abuse doses on oxidative stress processes in rats. Biomed. Pharmacother. 82 (2016), 355–363, 10.1016/j.biopha.2016.05.022.
40. Huh, Y.J., Kim, J.M., Kim, H., et al. Regulation of osteoclast differentiation by the redox-dependent modulation of nuclear import of transcription factors. Cell Death Differ. 13 (2006), 1138–1146.
41. Odkhyy, E., Koidel, N., Tsolmongyn, B., et al. Involvement of redox balance in in vitro osteoclast formation of RAW 264.7 macrophage cells in response to LPS. Innate Immun. 21 (2015), 194–202, 10.1177/1753425914524242.
42. Srivastava, S., Sinha, D., Saha, P.P., et al. Magmas functions as a ROS regulator and provides cytoprotection against oxidative stress-mediated damages. Cell Death Dis. 5 (2014), 1–15, 10.1038/cddis.2014.355.
43. Nur, E., Verwijs, M., de Waart, D.R., et al. Increased efflux of oxidized glutathione (GSSG) causes glutathione depletion and potentially diminishes antioxidant defense in sickle erythrocytes. Biochim. Biophys. Acta 1812 (2011), 1412–1417.
44. Mizuashi, M., Ohtani, T., Nakagawa, S., et al. Redox imbalance induced by contact sensitizers triggers the maturation of dendritic cells. J. Invest. Dermatol. 124 (2005), 579–586.
45. Zitka, O., Skalickova, S., Gumulec, J., et al. Redox status expressed as GSH:GSSG ratio as a marker for oxidative stress in paediatric tumour patients. Oncol. Lett. 4 (2012), 1247–1253.
46. Franzoni, F., Colognato, R., Galetta, F., et al. An in vitro study on the free radical scavenging capacity of ergothioneine: comparison with reduced glutathione, uric acid and trolox. Biomed. Pharmacother. 60:September (2006), 453–457 Epub 2006 Aug 14. PubMed PMID: 16930933.
47. Ungvari, Z., Orosz, Z., Rivera, A., et al. Resveratrol increases vascular oxidative stress resistance. Am. J. Physiol. Heart Circ. Physiol. 292 (2007), H2417–H2424.
48. Spanier, G., Xu, H., Xia, N., et al. Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4). J. Physiol. Pharmacol. 60 (2009), 111–116.
49. Strimpakos, A.S., Sharma, R.A., Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid. Redox Signal. 10 (2008), 511–545, 10.1089/ars.2007.1769 Review.
50. Hussain, T., Tan, B., Yin, Y., et al. Oxidative stress and inflammation: what polyphenols can do for us?. Oxid. Med. Cell. Longev. 2016 (2016), 1–9.
51. Mitjavila, M.T., Moreno, J.J., The effects of polyphenols on oxidative stress and the arachidonic acid cascade. Implications for the prevention/treatment of high prevalence diseases. Biochem. Pharmacol. 84:November (2012), 1113–1122, 10.1016/j.bcp.2012.07.017.
52. Li, Z., Geng, Y.N., Jiang, J.D., et al. Antioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus. Evid. Based Complement. Altern. Med. 2014 (2014), 1–22, 10.1155/2014/289264.
53. Ahmed, T., Gilani, A.U., Abdollahi, M., et al. Berberine and neurodegeneration: a review of literature. Pharmacol. Rep. 67 (2015), 970–979, 10.1016/j.pharep.2015.03.002.
54. Jang, M.H., Kim, H.Y., Kang, K.S., et al. Hydroxyl radical scaveing activities of isoquinoline alkaloids isolated from coptis chinensis. Arch. Pharm. Res. 32 (2009), 341–345, 10.1007/s12272-009-1305-z.
55. Jiang, J.F., Lei, F., Yuan, Z.Y., et al. Mechanism underlying berberine's effects on HSP70/TNFα under heat stress: correlation with the TATA boxes. Chin. J. Nat. Med. 15 (2017), 178–191, 10.1016/S1875-5364(17)30034-1.
56. Siow, Y.L., Sarna, L., Redox regulation in health and disease – therapeutic potential of berberine. Food Res. Int. 44 (2011), 2409–2417.
57. Shan, W.J., Huang, L., Zhou, Q., Meng, F.C., Li, X.S., Synthesis, biological evaluation of 9-N-substituted berberine derivatives as multi-functional agents of antioxidant, inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-β aggregation. Eur. J. Med. Chem. 46 (2011), 5885–5893, 10.1016/j.ejmech.2011.09.051.
58. Hur, J.M., Hyun, M.S., Lim, S.Y., et al. The combination of berberine and irradiation enhances anti-cancer effects via activation of p38 MAPK pathway and ROS generation in human hepatoma cells. J. Cell. Biochem. 107 (2009), 955–964, 10.1002/jcb.22198.
59. Sarna, L.K., Wu, N., Hwang, S.Y., et al. Berberine inhibits NADPH oxidase mediated superoxide anion production in macrophages. Can. J. Physiol. Pharmacol. 88 (2010), 369–378, 10.1139/Y09-136.
60. Lee, D.U., Kang, Y.J., Park, M.K., et al. Effects of 13-alkylsubstituted berberine alkaloids on the expression of COX-II, TNF-a, iNOS, and IL-12 production in LPS-stimulated macrophages. Life Sci. 73 (2003), 1401–1412.
61. Salminen, A., Kaarniranta, K., Kauppinen, A., Crosstalk between oxidative stress and SIRT1: impact on the aging process. Int. J. Mol. Sci. 14 (2013), 3834–3859, 10.3390/ijms14023834.
62. Giampieri, F., Alvarez-Suarez, J.M., Cordero, M.D., et al. Strawberry consumption improves aging-associated impairments, mitochondrial biogenesis and functionality through the AMP-activated protein kinase signaling cascade. Food Chem. 234 (2017), 464–471, 10.1016/j.foodchem.2017.05.017.
63. Serrano, J.C., Gonzalo-Benito, H., Jové, M., et al. Dietary intake of green tea polyphenols regulates insulin sensitivity with an increase in AMP-activated protein kinase α content and changes in mitochondrial respiratory complexes. Mol. Nutr. Food Res. 57 (2013), 459–470, 10.1002/mnfr.201200513.
64. Ferrali, M., Signorini, C., Caciotti, B., et al. Protection against oxidative damage of erythrocyte membrane by the flavonoid quercetin and its relation to iron chelating activity. FEBS Lett. 416 (1997), 123–129.
65. Frankel, E.N., Waterhouse, A.L., Kinsella, J.E., Inhibition of human LDL oxidation by resveratrol. Lancet 341 (1993), 1103–1104.
66. Loke, W.M., Proudfoot, J.M., Hodgson, J.M., et al. Specific dietary polyphenols attenuate atherosclerosis in apolipoprotein E-knockout mice by alleviating inflammation and endothelial dysfunction. Arterioscler. Thromb. Vasc. Biol. 30 (2010), 749–757, 10.1161/ATVBAHA.109.199687.
67. Hollman, P.C., Cassidy, A., Comte, B., et al. The biological relevance of direct antioxidant effects of polyphenols for cardiovascular health in humans is not established. J. Nutr. 141 (2011), 989S–1009S, 10.3945/jn.110.131490.
68. Haddad, J.J., Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors. Cell. Signal. 14 (2002), 879–897.
69. Duthie, G., Crozier, A., Plant-derived phenolic antioxidants. Curr. Opin. Lipidol. 11 (2000), 43–47.
70. Rice-Evans, C.A., Miller, N.J., Paganga, G., Structure-antioxidant activity relationshipsof flavonoids and phenolic acids. Free Radic. Biol. Med. 20 (1996), 933–956.
71. Kluth, D., Banning, A., Paur, I., et al. Modulation of pregnane X receptor-and electrophile responsive element-mediated gene expression by dietary polyphenolic compounds. Free Radic. Biol. Med. 42 (2007), 315–325.
72. Patel, R., Maru, G., Polymeric black tea polyphenols induce phase II enzymes via Nrf2 in mouse liver and lungs. Free Radic. Biol. Med. 44 (2008), 1897–1911, 10.1016/j.freeradbiomed.2008.02.006.
73. Belviranli, M., Okudan, N., Well-known antioxidants and newcomers in sport nutrition: coenzyme Q10, quercetin, resveratrol, pterostilbene, pycnogenol and astaxanthin. Lamprecht, M., (eds.) Source Antioxidants in Sport Nutrition, 2015, CRC Press/Taylor & Francis, Boca Raton (FL) Chapter 5.
74. Boots, A.W., Haenen, G.R., Bast, A., Health effects of quercetin: from antioxidant to nutraceutical. Eur. J. Pharmacol. 585 (2008), 325–337, 10.1016/j.ejphar.2008.03.008.
75. Hanasaki, Y., Ogawa, S., Fukui, S., The correlation between active oxygens scavenging and antioxidative effects of flavonoids. Free Radic. Biol. Med. 16 (1994), 845–850.
76. Cushnie, T.P., Lamb, A.J., Antimicrobial activity of flavonoids. Int. J. Antimicrob. Agents 26 (2005), 343–356 Review. Erratum in: Int J Antimicrob Agents. 2006;27:181.
77. Saw, C.L.L., Guo, Y., Yang, A.Y., et al. The berry constituents quercetin, kaempferol, and pterostilbene synergistically attenuate reactive oxygen species: involvement of the Nrf2-ARE signaling pathway. Food Chem. Toxicol. 72 (2014), 303–311, 10.1016/j.fct.2014.07.038.
78. Heijnen, C.G., Haenen, G.R., van Acker, F.A., et al. Flavonoids as peroxynitrite scavengers: the role of the hydroxyl groups. Toxicol. In Vitro 15 (2001), 3–6.
79. Heijnen, C.G., Haenen, G.R., Oostveen, R.M., et al. Protection of flavonoids against lipid peroxidation: the structure activity relationship revisited. Free Radic. Res. 36 (2002), 575–581.
80. Arts, I.C., Sesink, A.L., Faassen-Peters, M., et al. The type of sugar moiety is a major determinant of the small intestinal uptake and subsequent biliary excretion of dietary quercetin glycosides. Br. J. Nutr. 91:June (2004), 841–847.
81. Wolffram, S., Blöck, M., Ader, P., Quercetin-3-glucoside is transported by the glucose carrier SGLT1 across the brush border membrane of rat small intestine. J. Nutr. 132 (2002), 630–635.
82. Bhuiyan, M.N., Mitsuhashi, S., Sigetomi, K., et al. Quercetin inhibits advanced glycation end product formation via chelating metal ions, trapping methylglyoxal, and trapping reactive oxygen species. Biosci. Biotechnol. Biochem. 81 (2017), 882–890, 10.1080/09168451.2017.1282805.
83. Kukongviriyapan, U., Apaijit, K., Kukongviriyapan, V., Oxidative stress and cardiovascular dysfunction associated with cadmium exposure: beneficial effects of curcumin and tetrahydrocurcumin. Tohoku J. Exp. Med. 239 (2016), 25–38, 10.1620/tjem.239.25 Review.
84. Shen, L.R., Parnell, L.D., Ordovas, J.M., et al. Curcumin and aging. Biofactors 39 (2013), 133–140, 10.1002/biof.1086.
85. Reddy, A.C., Lokesh, B.R., Effect of dietary turmeric (Curcuma longa) on iron-induced lipid peroxidation in the rat liver. Food Chem. Toxicol. 32 (1994), 279–283.
86. Reddy, A.C., Lokesh, B.R., Studies on the inhibitory effects of curcumin and eugenol on the formation of reactive oxygen species and the oxidation of ferrous iron. Mol. Cell. Biochem. 137 (1994), 1–8.
87. Ahsan, H., Parveen, N., Khan, N.U., et al. Pro-oxidant, anti-oxidant and cleavage activities on DNA of curcumin and its derivatives demethoxycurcumin and bisdemethoxycurcumin. Chem. Biol. Interact. 121 (1999), 161–175.
88. Ak, T., Gülçin, I., Antioxidant and radical scavenging properties of curcumin. Chem. Biol. Interact. 174 (2008), 27–37, 10.1016/j.cbi.2008.05.003.
89. Borra, S.K., Mahendra, J., Gurumurthy, P., et al. Effect of curcumin against oxidation of biomolecules by hydroxyl radicals. J. Clin. Diagn. Res. 8 (2014), CC01–CC05, 10.7860/JCDR/2014/8517.4967.
90. Fujisawa, S., Atsumi, T., Ishihara, M., et al. Cytotoxicity, ros-generation activity and radical-scavenging activity of curcumin and related compounds. Anticancer Res. 24:2B (2004), 563–569.
91. Iio, M., Kawaguchi, H., Sakota, Y., et al. Rffects of polyphenols, including flavonoids, on glutathione S-transferase and glutathione reductase. Biosci. Biotechnol. Biochem. 57 (1993), 1678–1680, 10.1271/bbb.57.1678.
92. Moskaug, J.Ø, Carlsen, H., Myhrstad, M.C., et al. Polyphenols and glutathione synthesis regulation. Am. J. Clin. Nutr. 81 (2005), 277S–283S Review.
93. Lao-ong, T., Chatuphonprasert, W., Nemoto, N., et al. Alteration of hepatic glutathione peroxidase and superoxide dismutase expression in streptozotocin-induced diabetic mice by berberine. Pharm. Biol. 50 (2012), 1007–1012, 10.3109/13880209.2012.655377.
94. Bacanlı, M., Aydın, S., Taner, G., et al. The protective role of ferulic acid on sepsis-induced oxidative damage in Wistar albino rats. Environ. Toxicol. Pharmacol 38 (2014), 774–782, 10.1016/j.etap.2014.08.018.
95. St-Laurent-Thibault, C., Arseneault, M., Longpré, F., et al. Tyrosol and hydroxytyrosol, two main components of olive oil, protect N2a cells against amyloid-β-induced toxicity. involvement of the NF-κB signaling. Curr. Alzheimer Res. 8 (2011), 543–551.
96. Reyes-Gordillo, K., Segovia, J., Shibayama, M., et al. Curcumin protects against acute liver damage in the rat by inhibiting NF-kappaB, proinflammatory cytokines production and oxidative stress. Biochim. Biophys. Acta 1770 (2007), 989–996.
97. Lavoie, S., Chen, Y., Dalton, T.P., et al. Curcumin, quercetin, and tBHQ modulate glutathione levels in astrocytes and neurons: importance of the glutamate cysteine ligase modifier subunit. J. Neurochem. 108 (2009), 1410–1422, 10.1111/j.1471-4159.2009.05908.
98. Li, C., Zhang, W.J., Choi, J., et al. Quercetin affects glutathione levels and redox ratio in human aortic endothelial cells not through oxidation but formation and cellular export of quercetin-glutathione conjugates and upregulation of glutamate-cysteine ligase. Redox Biol. 9 (2016), 220–228, 10.1016/j.redox.2016.08.012.
99. Lee, G.H., Lee, H.Y., Choi, M.K., et al. Protective effect of Curcuma longa L. extract on CCl(4)-induced acute hepatic stress. BMC Res. Notes, 10, 2017, 77, 10.1186/s13104-017-2409-z.
100. Elliott, P.J., Jirousek, M., Sirtuins: novel targets for metabolic disease. Curr. Opin. Investig. Drugs 9 (2008), 371–378 Review.
101. Tanno, M., Kuno, A., Yano, T., et al. Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure. J. Biol. Chem. 285 (2010), 8375–8382, 10.1074/jbc.M109.090266.
102. Alcendor, R.R., Gao, S., Zhai, P., et al. Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ. Res. 100 (2007), 1512–1521.
103. Brunet, A., Sweeney, L.B., Sturgill, J.F., et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303 (2004), 2011–2015.
104. Kawai, Y., Garduño, L., Theodore, M., et al. Acetylation-deacetylation of the transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) regulates its transcriptional activity and nucleocytoplasmic localization. J. Biol. Chem. 286 (2011), 7629–7640, 10.1074/jbc.M110.208173.
105. Tanito, M., Agbaga, M.P., Anderson, R.E., Upregulation of thioredoxin system via Nrf2-antioxidant responsive element pathway in adaptive-retinal neuroprotection in vivo and in vitro. Free Radic. Biol. Med. 42 (2007), 1838–1850.
106. Lamberts, R.R., Onderwater, G., Hamdani, N., et al. Reactive oxygen species-induced stimulation of 5′AMP-activated protein kinase mediates sevoflurane-induced cardioprotection. Circulation 120 (2009), S10–S15.
107. Toyoda, T., Hayashi, T., Miyamoto, L., et al. Possible involvement of the α1 isoform of 5′AMP-activated protein kinase in oxidative stress-stimulated glucose transport in skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 287 (2004), E166–E173.
108. Emerling, B.M., Weinberg, F., Snyder, C., et al. Hypoxic activation of AMPK is dependent on mitochondrial ROS but independent of an increase in AMP/ATP ratio. Free Radic. Biol. Med. 46 (2009), 1386–1391, 10.1016/j.freeradbiomed.2009.02.019.
109. Choi, S.L., Kim, S.J., Lee, K.T., et al. The regulation of AMPactivated protein kinase by H2O2. Biochem. Biophys. Res. Commun. 287 (2001), 92–97, 10.1006/bbrc.2001.5544.
110. Zmijewski, J.W., Banerjee, S., Bae, H., Friggeri, A., Lazarowski, E.R., Abraham, E., Exposure tohydrogen peroxide induces oxidation and activation of AMP-activated protein kinase. J. Biol. Chem. 285 (2010), 33154–33164, 10.1074/jbc.M110.143685.
111. Xie, Z., Dong, Y., Zhang, M., et al. Activation of protein kinase Cζ by peroxynitrite regulates LKB1-dependent AMP-activated protein kinase in cultured endothelial cells. J. Biol. Chem. 281 (2006), 6366–6375.
112. Lassègue, B., Griendling, K.K., NADPH oxidases: functions and pathologies in the vasculature. Arterioscler. Thromb. Vasc. Biol. 30 (2010), 653–661, 10.1161/ATVBAHA.108.181610.
113. Guzik, T.J., Mussa, S., Gastaldi, D., Sadowski, J., Ratnatunga, C., Pillai, R., Channon, K.M., Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 105 (2002), 1656–1662.
114. Gao, L., Mann, G.E., Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling. Cardiovasc. Res. 82 (2009), 9–20, 10.1093/cvr/cvp031 Review.
115. Brandes, R.P., Weissmann, N., Schröder, K., NADPH oxidases in cardiovascular disease. Free Radic. Biol. Med. 49:5 (September 1) (2010), 687–706, 10.1016/j.freeradbiomed.2010.04.030.
116. Alba, G., El Bekay, R., Alvarez-Maqueda, M., et al. Stimulators of AMP-activated protein kinase inhibit the respiratory burst in human neutrophils. FEBS Lett. 573 (2004), 219–225.
117. Hwang, J., Kleinhenz, D.J., Rupnow, H.L., et al. The PPARgamma ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice. Vasc. Pharmacol. 46 (2007), 456–462.
118. Piwkowska, A., Rogacka, D., Jankowski, M., et al. Metformin induces suppression of NAD(P)H oxidase activity in podocytes. Biochem. Biophys. Res. Commun. 393 (2010), 268–273, 10.1016/j.bbrc.2010.01.119.
119. D'Archivio, M., Filesi, C., Varì, R., et al. Bioavailability of the polyphenols: status and controversies. Int. J. Mol. Sci. 11 (2010), 1321–1342, 10.3390/ijms11041321.
120. Giovannini, L., Bianchi, S., Role of nutraceutical SIRT1 modulators in AMPK and mTOR pathway: evidence of a synergistic effect. Nutrition 34 (2017), 82–96, 10.1016/j.nut.2016.09.008.
121. Morand, C., Sies, H., Polyphenols and health. Arch. Biochem. Biophys. 599 (2016), 1–2, 10.1016/j.abb.2016.03.015.
122. Teixeira, J., Chavarria, D., Borges, F., et al. Dietary polyphenols and mitochondrial function: role in health and disease. Curr. Med. Chem., 2017, 10.2174/0929867324666170529101810.
123. Ganesan, K., Xu, B., A critical review on polyphenols and health benefits of black soybeans. Nutrients, 2017, 10.3390/nu9050455.